Ryvu Therapeutics raises €22M from EIB to make new cancer treatments

On Wednesday, Poland-based Ryvu Therapeutics, a biopharmaceutical company developing small molecule drugs to treat cancer, received 22 million euros from The European Investment Bank (EIB). The European Investment Plan is providing the money through their venture debt instrument. This funding is for businesses that are growing very fast, and needs to be used in a […]